Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating activities:
Net income	$ 6,110	$ 14,144
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	18,606	15,352
Noncash rental revenue including straight-line rents	(4,220)	(2,617)
Gain on sales of real estate assets	(2,505)	(24,758)
Amortization of terminated swap agreements and related income tax benefit	(1,812)	66
Stock-based compensation expense	1,492	1,110
Amortization of debt issuance costs	898	1,047
Losses on early extinguishment of debt	653	74
Gain on sales of equipment	(203)
Noncash impairment charge		3,000
Change in fair value of financial instruments		2,746
Changes in assets and liabilities:
Other assets	(2,222)	(656)
Accounts payable and accrued liabilities	2,324	148
Deferred revenue	1,412	243
Other liabilities	(1,563)	954
Net cash provided by operating activities	18,970	10,853
Investing activities:
Acquisitions of land and buildings	(63,413)	(125,599)
Additions to real estate assets	(58,422)	(47,703)
Proceeds from sales of real estate assets, net of expenses	10,392	42,344
Deposits on building and land acquisitions	(5,788)	(9,800)
Deferred leasing costs and other	(2,660)	(3,282)
Proceeds from sale of equipment, net of expenses	250
Net cash used in investing activities	(119,641)	(144,040)
Financing activities:
Principal payments on mortgage loans and construction loan	(91,278)	(17,100)
Proceeds from delayed draw term loan and construction loan	90,069	26,273
Dividends paid to stockholders	(6,521)	(5,721)
Payment of debt issuance costs	(1,508)	(1,886)
Proceeds from (payment for) termination of interest rate swap agreements	1,227	(66)
Proceeds from exercise of stock options	147	442
Proceeds from sale of common stock		261,477
Net cash (used in) provided by financing activities	(7,864)	263,419
Net (decrease) increase in cash and cash equivalents and restricted cash	(108,535)	130,232
Cash and cash equivalents and restricted cash at beginning of period	160,907	30,675
Cash and cash equivalents and restricted cash at end of period	$ 52,372	$ 160,907